powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1376070300
Marcelo Vailati Negrao
M.D.
Medical Oncology
Houston,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
217
Beneficiaries
—
Total drug cost
$2.4M
Distinct drugs
6
Brand share
64.1%
Top prescribed drugs
Osimertinib Mesylate
104 claims
Adagrasib
35 claims
Ondansetron Hcl
25 claims
Dexamethasone
21 claims
Prochlorperazine Maleate
18 claims
QUALITY · MIPS · 2024
Final MIPS score
84.3
Quality
70.8
Cost
67.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$4K
Payment records
7
By payment type
Consulting Fee
$3K
Food and Beverage
$379
Top paying entities
Consulting Fee
$3K
Food and Beverage
$379
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
232
Unique beneficiaries
—
Total services
564
Distinct HCPCS
5
Medicare payment
$57K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 393 Medical Oncology providers in TX — below median (cohort median 4,999).